Literature DB >> 30325570

Tuberous sclerosis complex.

Angela Peron1,2, Hope Northrup3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30325570     DOI： 10.1002/ajmg.c.31657

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN： 1552-4868            Impact factor:   3.908


× No keyword cloud information.
  6 in total

Review 1.  Brain Organoids as Tools for Modeling Human Neurodevelopmental Disorders.

Authors:  Jason W Adams; Fernanda R Cugola; Alysson R Muotri
Journal:  Physiology (Bethesda)       Date:  2019-09-01

2.  Preliminary Screening of a Familial Tuberous Sclerosis Complex Pathogenic Gene.

Authors:  Yuting Wang; SongNian Hu; XinYu Tan; Qingqing Sang; Peng Shi; Chun Wang; Daoqian Sang
Journal:  Int J Gen Med       Date:  2022-05-26

3.  Epilepsy in adult patients with tuberous sclerosis complex.

Authors:  Aglaia Vignoli; Francesca La Briola; Katherine Turner; Angela Peron; Chiara Vannicola; Valentina Chiesa; Elena Zambrelli; Fabio Bruschi; Ilaria Viganò; Maria Paola Canevini
Journal:  Acta Neurol Scand       Date:  2021-03-22       Impact factor: 3.209

Review 4.  Multifocal micronodular pneumocyte hyperplasia lacking typical clinical features of the tuberous sclerosis complex: a case report and literature review.

Authors:  Shan Li; Chaojie Wu; Qiyun Ma; Xueqin Chen; Wei Zhang; Xiao Li; Mao Huang; Ningfei Ji
Journal:  BMC Pulm Med       Date:  2022-03-05       Impact factor: 3.317

5.  Genotype and Phenotype Analysis of Chinese Children With Tuberous Sclerosis Complex: A Pediatric Cohort Study.

Authors:  Yifeng Ding; Ji Wang; Shuizhen Zhou; Yuanfeng Zhou; Linmei Zhang; Lifei Yu; Yi Wang
Journal:  Front Genet       Date:  2020-03-10       Impact factor: 4.599

6.  Quality of life in children with tuberous sclerosis complex: A pediatric cohort study.

Authors:  Yifeng Ding; Ji Wang; Yuanfeng Zhou; Lifei Yu; Linmei Zhang; Shuizhen Zhou; Yi Wang
Journal:  CNS Neurosci Ther       Date:  2020-11-23       Impact factor: 5.243
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.